Abstract:Objective To compare mifepristone plus a misoprostol-combined regimen with misoprostol alone in the medical abortion of first trimester pregnancy. Methods An internet-based search of available literature was performed using text words contained in titles and abstracts. PubMed/Medline, Cochrane CENTRAL, EMBASE, and Google scholar were used to locate English-based articles published until December 2021. Studies fulfilling the inclusion criteria were selected, appraised, and assessed for methodological quality. The included studies were pooled for meta-analysis, and the results were presented in risk ratio at a 95% confidence interval. Findings Nine studies comprising 2,052 participants (1,035 intervention and 1,017 controls) were considered. Primary endpoints were complete expulsion, incomplete expulsion, missed abortion, and ongoing pregnancy. The intervention was found to more likely induce complete expulsion irrespective of gestational age (RR: 1.19; 95% CI: 1.14–1.25). The administration of misoprostol 800 mcg after 24 h of mifepristone pre-treatment in the intervention group more likely induced complete expulsion (RR: 1.23; 95% CI: 1.17–1.30) than after 48 h. The intervention group was also more likely to experience complete expulsion when misoprostol was used either vaginally (RR: 1.16; 95% CI: 1.09–1.17) or buccally (RR: 1.23; 95% CI: 1.16–1.30). The intervention was more effective in the subgroup with a negative foetal heartbeat at reducing incomplete abortion (RR: 0.45; 95% CI: 0.26–0.78) compared with the control group. The intervention more likely reduced both missed abortion (RR: 0.21; 95% CI: 0.08–0.91) and ongoing pregnancy (RR: 0.12; 95% CI: 0.05–0.26). Fever was less likely to be reported (RR: 0.78; 95% CI: 0.12–0.89), whereas the subjective experience of bleeding was more likely to be encountered (RR: 1.31; 95% CI: 1.13–1.53) by the intervention group. Conclusion The review strengthened the theory that a combined mifepristone and misoprostol regimen can be an effective medical management for inducing abortions during first trimester pregnancy in all contexts. Specifically, there is a high-level certainty of evidence on complete expulsion during the early stage and its ability to reduce both missed and ongoing pregnancies. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019134213 , identifier CRD42019134213.

Clinical Study of Termination of Early Pregnancy in 7-9 Weeks Gestation

Preliminary study on the effect of mifepristone followed by diffferent regimens of misoprostol for termination of pregnancy between 8 and 16 weeks of gestation

The Retrospective Analysis on the Influence of Taking Mifepristone and Misoprostol During First-trimester Pregnancy and Its Following Impact on Tissue Residual After Induced Abortion

Analysis of Mifeprestone Combine Misoprostol Induced Early Pregnancy Ending after Cesarean Section

Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8–16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial

Mifepristone Combined with Misoprostol Versus Intra-Amniotic Injection of Ethacridine Lactate for the Termination of Second Trimester Pregnancy: a Prospective, Open-Label, Randomized Clinical Trial

Mifepristone in Combination with Prostaglandins for Termination of 10–16 Weeks’ Gestation: a Systematic Review

The Application of Mifepristone Complicated Misoprostol for the Termination of Pregnancy with 12～14 Gestational Weeks in the Embryulcia Surgery

Clinical Effect of Three Different Methods in Termination of Midtrimester Pregnancy

Different intervals of misoprostol administration for termination of second trimester pregnancy:a randomized controlled trail

One- and two-day mifepristone–misoprostol intervals for second trimester termination of pregnancy between 13 and 16weeks of gestation

The Efficacy and Influence Factors Analysis of Mifepristone Combined with Estrogen-Progesterone in the Treatment of Incomplete Abortion

Investigation of the 12-Month Efficacy and Safety of Low-Dose Mifepristone in the Treatment of Painful Adenomyosis

Study on the Effects of Mifepristone and Misoprostol to Terminate the Medium-Term Pregnancy

Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion

Medical termination of pregnancy from day 85 to day 153 of gestation: A randomized comparison between administration of the initial dose of misoprostol at home or in the clinic

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis

Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century

The second trimester termination with combination of mifepristone and misoprostol:A randomized comparison with dry and sodium chloride solution-moistened misoprostol tablets administered intravaginally

Efficacy and Safety of Mifepristone and Misoprostol Compared to Misoprostol Alone for the Resolution of Miscarriage and Intrauterine Fetal Death: A Systematic Review and Meta-Analysis

Observation on the curative effect of different dose of mifepristone capsules on termination of cesarean scar pregnancy at 10-14 gestational weeks